Cargando…
A novel protective role of sacubitril/valsartan in cyclophosphamide induced lung injury in rats: impact of miRNA-150-3p on NF-κB/MAPK signaling trajectories
Cyclophosphamide (CP) is a chemotherapeutic agent that induces oxidative stress causing multiple organ damage. Sacubitril/valsartan, is a combined formulation of neprilysin inhibitor (sacubitril) and angiotensin II receptor blocker (valsartan), that induces the protective effect of brain natriuretic...
Autores principales: | Abdel-Latif, Ghada A., Elwahab, Azza H. Abd, Hasan, Rehab A., ElMongy, Noura F., Ramzy, Maggie M., Louka, Manal L., Schaalan, Mona F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7400763/ https://www.ncbi.nlm.nih.gov/pubmed/32747644 http://dx.doi.org/10.1038/s41598-020-69810-5 |
Ejemplares similares
-
Sacubitril/Valsartan Conundrum
por: Somberg, John
Publicado: (2021) -
Implication of low dose sacubitril/valsartan
por: Imamura, Teruhiko
Publicado: (2021) -
Eligibility and Usage of Sacubitril/Valsartan in Korea
por: Kim, Jin-Jin, et al.
Publicado: (2019) -
Sacubitril/valsartan increases postprandial gastrin and cholecystokinin in plasma
por: Andersen, Ulrik Ø, et al.
Publicado: (2020) -
Insights into implementation of sacubitril/valsartan into clinical practice
por: Martens, Pieter, et al.
Publicado: (2018)